Olympus (OTCMKTS:OCPNY) Shares Pass Below 200 Day Moving Average – What’s Next?

Olympus Co. (OTCMKTS:OCPNY)’s stock price passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $18.00 and traded as low as $18.00. Olympus shares last traded at $18.00, with a volume of 400 shares trading hands.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group upgraded Olympus to a “buy” rating in a research note on Monday, May 18th. One analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, Olympus has a consensus rating of “Buy”.

Olympus Stock Performance

The stock has a market capitalization of $23.15 billion, a price-to-earnings ratio of 21.95, a P/E/G ratio of 1.07 and a beta of 0.70. The company’s fifty day simple moving average is $18.00 and its 200 day simple moving average is $18.00. The company has a quick ratio of 1.48, a current ratio of 1.99 and a debt-to-equity ratio of 0.59.

Olympus Company Profile

Olympus Corporation is a Tokyo-headquartered manufacturer specializing in medical and scientific imaging, precision optics and related equipment. The company’s medical systems business is focused on endoscopic technologies and therapeutic devices used in minimally invasive diagnosis and treatment, supplying hospitals and clinical facilities with endoscopes, visualization platforms and accessories. In addition to healthcare, Olympus serves scientific and industrial customers with microscopes, imaging systems, non-destructive testing equipment and precision measurement tools used in research, manufacturing and quality control.

In recent years the company completed a strategic refocus on healthcare and scientific solutions, divesting its consumer camera business in 2020 to concentrate resources on medical device development, services and life-science applications.